Clinical Trial Update: Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A phase 3 study compares ZG006 with investigator-selected chemotherapy in relapsed small cell lung cancer. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• ZG006

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Small-cell Lung Cancer | Phase 3 | Status: RECRUITING